FDMT Net Income Per Share from 2010 to 2024

FDMT Stock  USD 8.53  0.08  0.95%   
4D Molecular Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to -2.71 in 2024. From the period from 2010 to 2024, 4D Molecular Net Loss quarterly data regression had mean square error of  0.22 and mean deviation of  0.84. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(2.58)
Current Value
(2.71)
Quarterly Volatility
0.91629835
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 4D Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 4D Molecular's main balance sheet or income statement drivers, such as Net Interest Income of 9.6 M, Interest Income of 9.6 M or Depreciation And Amortization of 4.2 M, as well as many indicators such as Price To Sales Ratio of 36.34, Dividend Yield of 0.0 or PTB Ratio of 2.7. FDMT financial statements analysis is a perfect complement when working with 4D Molecular Valuation or Volatility modules.
  
Check out the analysis of 4D Molecular Correlation against competitors.

Latest 4D Molecular's Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of 4D Molecular Therapeutics over the last few years. It is 4D Molecular's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 4D Molecular's overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

FDMT Net Income Per Share Regression Statistics

Arithmetic Mean(1.45)
Coefficient Of Variation(63.03)
Mean Deviation0.84
Median(0.76)
Standard Deviation0.92
Sample Variance0.84
Range2.3678
R-Value(0.87)
Mean Square Error0.22
R-Squared0.75
Significance0.000026
Slope(0.18)
Total Sum of Squares11.75

FDMT Net Income Per Share History

2024 -2.71
2023 -2.58
2022 -3.12
2021 -2.46
2020 -2.12
2019 -2.0

About 4D Molecular Financial Statements

4D Molecular shareholders use historical fundamental indicators, such as Net Income Per Share, to determine how well the company is positioned to perform in the future. Although 4D Molecular investors may analyze each financial statement separately, they are all interrelated. The changes in 4D Molecular's assets and liabilities, for example, are also reflected in the revenues and expenses on on 4D Molecular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss(2.58)(2.71)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for FDMT Stock Analysis

When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.